Todos Medical announced first commercial sale of COVID-19 antibody tests
On May 18, 2020, Todos Medical announced its first commercial sale of COVID-19 tests. The sale was made…
-
-
Biotechnology | COVID-19 | Infectious Disease | NIH | USDA | Vaccine
Investigational ChAdOx1 nCoV-19 vaccine protects monkeys against COVID-19 pneumonia
On May 16, 2020, a single dose of ChAdOx1 nCoV-19, an investigational vaccine against SARS-CoV-2, has protected six…
-
Duke-NUS, GenScript and A*STAR launched first-in-the-world SARS-CoV-2 serology test
On May 15, 2020, Duke-NUS Medical School, GenScript Biotech, and the Diagnostics Development Hub at Singapore’s Agency for…
-
CIRM board approved clinical trials targeting COVID-19 and sickle cell disease
On May 15, 2020, the California Institute for Regenerative Medicine (CIRM) board approved new clinical trials for COVID-19…
-
Abbott provided update on ID NOW
On May 14, 2020, Abbott’s ID NOW announced that was further clarifying product information to provide better guidance…
-
The FDA informed public about possible accuracy concerns with Abbott ID NOW point-of-care test
On May 14, 2020, the U.S. Food and Drug Administration (FDA) alerted the public to early data that…
-
Abivax received ANSM and ethics committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized phase 2b/3 clinical trial
On May 14, 2020 Abivax announced it had received clearance from France’s National Agency for the Safety of…
-
Vyriad announced development of new antibody test to determine protective immunity from COVID-19
On May 14, 2020 Vyriad announced that it had completed the development of a serology test to measure…
-
Countries begin large-scale screening for SARS-CoV-2 in sewage
On May 14, 2020,The Scientist reported that scientists in Spain are expecting to begin regularly analyzing sewage for…
-
First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine development
On May 14, 2020, scientists at La Jolla Institute for Immunology (LJI) announced they had resolved the uncertainty…
-
University of Alberta researchers launched a joint effort with US-based Tonix Pharma to develop and test a vaccine against COVID-19
On May 13, 2020, University of Alberta (UA) researchers launched a joint effort with U.S.-based Tonix Pharmaceuticals to…
-
Biotechnology | Diagnostics | Infectious Disease | Influenza | Measles | Plague | Vaccine
BioMed X Institute launched rapid antiviral response platform to prevent future pandemics
On May 13, 2020, BioMed X, an independent research institute that identifies big biomedical research challenges and provides…
-
Thermo Fisher Scientific response to COVID-19 expanded to include new serology test
On May 13, 2020, Thermo Fisher Scientific announced it will expand its response to the COVID-19 pandemic by…
-
University of Nebraska developed a COVID-19 screening mobile app
On May 13, 2020, a new protective device that is expected to help protect healthcare workers everywhere from…
-
Catalent signed development agreement with Ennaid Therapeutics on its COVID-19 lead program
On May 13, 2020, Catalent announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at…
-
Immunic received regulatory approval from German Health Authority BfArM to initiate phase 2 clinical trial in COVID-19 patients
On May 13, 2020, Immunic announced that it had received first regulatory approval from Germany’s BfArM (Bundesinstitut für…
-
Study confirmed cats can become infected with and may transmit COVID-19 to other cats
On May 13, 2020, in a study published in the New England Journal of Medicine, scientists in the…
-
Biotechnology | COVID-19 | FDA | Infectious Disease | Therapeutics | WHO
Mylan to supply investigational antiviral remdesivir for potential treatment of COVID-19
On May 12, 2020, Mylan announced, as part of its ongoing efforts to support patients and public health…
-
National Research Council of Canada and CanSino Biologics announced collaboration to advance vaccine against COVID-19
On May 12, 2020, the National Research Council of Canada (NRC) announced a collaboration with CanSino Biologics to…
-
Abbott received FDA Emergency Use Authorization for COVID-19 Molecular Test on New Alinity mﾙ System
On May 12, 2020, Abbott announced the U.S. Food and Drug Administration (FDA) had issued an Emergency Use…
-
National Research Council of Canada and USasks VIDO-InterVac collaborated to advance development of vaccine against COVID-19
On May 12, 2020, the National Research Council of Canada (NRC) and the University of Saskatchewan’s (USask) Vaccine…
-
U.S. Dept. of Veterans Affairs accepted mask donation from South Korea to assist with COVID-19 efforts
On May 12, 2020, the U.S. Dept. of Veterans Affairs (VA) announced it had accepted a donation of…
-
The Jackson Laboratory provided widescale COVID-19 testing in Connecticut
On May 12, 2020, the Jackson Laboratory (JAX), in partnership with the State of Connecticut, announced that it…
-
FDA further expanded EUA for Thermo Fisher Scientific’s COVID-19 diagnostic tests
On May 12, 2020, Thermo Fisher Scientific announced the FDA has further expanded emergency use authorization (EUA) for…
-
Combing through old drugs to find new ones for COVID-19
On May 12, 2020, the Broad Institute’s Drug Repurposing Hub announced that it had opened its repository of…
-
LabCorp significantly expanded availability of Its COVID-19 at-home collection test kit
On May 12, 2020, LabCorp announced that its COVID-19 at-home collection test kit is now being offered to…
-
U of Alberta pharmaceutical institute leads effort to fill looming hospital drug shortage during fight against COVID-19
On May 11, 2020, a University of Alberta-initiated institute leads province wide effort to fill the looming shortage…
-
The FDA announced actions to accelerate development of novel prevention, treatment options for COVID-19
On May 11, 2020, the U.S. Food and Drug Administration (FDA) announced actions to accelerate the development of…
-
Todos Medical entered Into exclusive distribution agreement with Gnomegen and received FDA Emergency Use Authorization for COVID-19 qPCR test kits
On May 11, 2020, Todos Medical announced an exclusive distribution agreement with Gnomegen for the distribution of its…
-
Biotechnology | COVID-19 | FDA | Infectious Disease | NIH | Vaccine
NIH report coordinated strategy to accelerate multiple COVID-19 vaccine candidates is key
On May 11, 2020, a harmonized and collaborative approach to the clinical testing, scale-up and distribution of candidate…
